Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 ISIN · CNE100000FN7 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,603 across all filing types
Latest filing 2025-04-07 Regulatory Filings
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Regulatory Filings Classification · 60% confidence The document is a monthly return (Form FF301) filed by a Hong Kong listed issuer to HKEX showing movements in authorised, issued, and treasury shares for the month ended 31 March 2025. It is a regulatory submission that does not announce a specific corporate action (e.g., dividends, M&A, financing) or present an annual/interim report or earnings release. It is not merely announcing publication of another report, but is itself a routine regulatory filing for share movements. This does not fit the specialized categories for dividends, share issues, or financial reports, so it falls under the fallback placeholder for miscellaneous regulatory filings.
2025-04-07 English
PROPOSED DISTRIBUTION OF FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS
Notice of Dividend Amount Classification · 95% confidence The document is an official Hong Kong Stock Exchange announcement (form EF001) titled “Cash Dividend Announcement for Equity Issuer” for Sinopharm Group Co. Ltd., specifying the final dividend per share, ex-dividend date, record date, payment date, and related withholding tax details. This matches the definition of a Notice of Dividend Amount.
2025-03-23 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
Earnings Release Classification · 90% confidence The document is titled “Annual Results Announcement for the year ended 31 December 2024” and originates from a Hong Kong Exchange announcement. It includes the Chairman’s Statement, detailed consolidated financial statements (profit or loss, comprehensive income, financial position, etc.) for the full year. It is not simply a notice that the full Annual Report is available, nor is it a regulatory filing like a 10-K or an Interim Report. It serves as the initial public release of the year-end results—i.e., an earnings release. Therefore, it best fits the Earnings Release (ER) category. FY 2024
2025-03-23 English
ANNOUNCEMENT PRINCIPAL FINANCIAL DATA OF CNMDC FOR THE YEAR ENDED 31 DECEMBER 2024
Earnings Release Classification · 85% confidence The document is an exchange announcement under HKEx listing rules (Rule 13.09) providing principal audited financial data for the year ended 31 December 2024. It summarizes key financial metrics (revenue, profit, cash flow, assets, equity) without attaching a full annual report. This matches an initial announcement of periodical financial results (key highlights only), which corresponds to an Earnings Release (ER) rather than a full Annual Report (10-K) or a mere publication notice (RPA). FY 2024
2025-03-20 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-03-20 English
ANNOUNCEMENT PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM (CNCM LTD) FOR THE YEAR ENDED 31 DECEMBER 2024
Earnings Release Classification · 80% confidence The document is a Hong Kong Exchange announcement pursuant to Listing Rule 13.09 and SFO Part XIVA providing key audited principal accounting data and financial indicators for the year ended 31 December 2024. It only includes high-level headline figures (revenue, net profit, EPS, ROE) and brief commentary, rather than a full annual report or detailed financial statements. This matches the definition of an Earnings Release (initial announcement of periodical financial results with key highlights). FY 2024
2025-03-19 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.